Product image of Norditropin Nordilet (Somatropin) supplied by GNH India

Norditropin Nordilet

Active Ingredient:
Somatropin
Origin:
EU

Norditropin Nordilet (Somatropin)

Somatropin, the active ingredient in Norditropin Nordilet, is a growth hormone presented as an unknown/unknown for subcutaneous use. It is prescribed to address growth hormone deficiency and related growth disorders in children and adults, supporting normal growth and metabolic functions.

GNH India supplies Norditropin Nordilet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality‑controlled manufacturing, regulatory compliance and reliable cold‑chain logistics for this biologic product. All shipments meet stringent temperature monitoring to preserve product integrity.

Manufacturer / TM Owner

Novo Nordisk A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Norditropin Nordilet (somatropin) is used in endocrine and genetic conditions where growth hormone pathways are deficient or impaired.

  • Growth hormone deficiency: restores normal growth velocity in children and improves metabolic parameters in adults.
  • Turner syndrome: promotes linear growth and improves final adult height in affected females.
  • Chronic renal insufficiency: compensates for reduced endogenous growth hormone activity, supporting growth and protein synthesis.
  • Prader‑Willi syndrome: aids in increasing height and body composition when combined with diet and therapy.
  • Idiopathic short stature: enhances growth rate in children with unexplained growth failure.

How It Works

  • Somatropin binds to specific growth hormone receptors on target cells, activating the JAK2‑STAT5 signaling cascade. This stimulates hepatic synthesis of insulin‑like growth factor‑1 (IGF‑1) and other downstream mediators that promote proliferation of chondrocytes in growth plates, increase protein synthesis, and enhance lipolysis, collectively supporting linear growth and metabolic regulation. The increased IGF‑1 also exerts endocrine effects on bone remodeling and muscle mass, reinforcing the anabolic actions of growth hormone throughout the body.

Side Effects

Somatropin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Injection site pain: mild discomfort or erythema at the injection site.
  • Headache: transient headache occurring after dosing.
  • Edema: peripheral swelling, especially in the ankles.
  • Hyperglycemia: elevated blood glucose levels, particularly in predisposed individuals.
  • Nausea: occasional feeling of queasiness after injection.
  • Fatigue: persistent tiredness reported by some patients.

Serious or Rare Side Effects

  • Intracranial hypertension: signs include severe headache, visual disturbances, and nausea.
  • Antibody formation: development of neutralizing antibodies reducing drug efficacy.

Precautions & Warnings

Before initiating somatropin therapy, clinicians should evaluate several safety considerations.

  • Baseline assessment: obtain IGF‑1 and growth hormone levels to confirm deficiency.
  • Diabetes monitoring: regularly check blood glucose, as therapy may worsen hyperglycemia.
  • Intracranial pressure: assess for symptoms of increased intracranial pressure before and during treatment.
  • Thyroid function: evaluate thyroid status, since hypothyroidism can affect response.
  • Pregnancy and lactation: avoid use unless benefits outweigh risks; discuss with obstetric specialist.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Somatropin can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

  • Glucocorticoids: high doses may blunt growth response to somatropin.
  • Antidiabetic agents: concurrent use may require dose adjustment of insulin or oral hypoglycemics.

Moderate Interactions (Monitor Closely)

  • Estrogen therapy: may increase IGF‑1 levels, necessitating careful monitoring.
  • Thyroid hormone replacement: adjust levothyroxine dose as metabolism changes.
  • CYP enzyme inducers: may affect hormone metabolism, though clinical impact is limited.

Frequently Asked Questions

Norditropin Nordilet contains somatropin, a recombinant human growth hormone. It is prescribed to treat growth hormone deficiency, Turner syndrome, chronic renal insufficiency, Prader‑Willi syndrome, and idiopathic short stature, helping patients achieve normal growth and improve metabolic outcomes.

Somatropin binds to growth hormone receptors on target cells, triggering the JAK2‑STAT5 pathway. This increases hepatic production of insulin‑like growth factor‑1 (IGF‑1), which stimulates bone growth, protein synthesis, and lipolysis, thereby promoting linear growth and metabolic regulation.

Dosing of somatropin is individualized. The prescribing clinician determines the exact amount, frequency, and duration based on the patient’s age, weight, diagnosis, and IGF‑1 response. No fixed regimen can be provided without a medical assessment.

Safety data are limited. Somatropin is generally avoided in pregnancy and lactation unless the potential benefit justifies the risk. Physicians should discuss the individual situation with obstetric and pediatric specialists before use.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, cold‑chain shipping details, and necessary import documentation.

Norditropin Nordilet is a recombinant human growth hormone similar in efficacy to other brands such as Genotropin or Humatrope. Differences may lie in formulation, device design, and stability profile. Clinical choice often depends on physician preference, patient convenience, and supply chain considerations.

The product must be stored refrigerated at 2‑8 °C. Keep it in the original packaging, protect it from light, and avoid freezing or shaking. Once reconstituted, use within the time frame specified by the manufacturer and maintain cold‑chain conditions during transport.

Norditropin Nordilet is given by subcutaneous injection, typically into the thigh, abdomen, or upper arm. The injection site should be rotated to reduce local irritation. Administration is performed by a healthcare professional or a trained caregiver following aseptic technique.

Serious adverse events include intracranial hypertension, which may present with severe headache and visual changes, and the development of neutralizing antibodies that diminish drug efficacy. Hyperglycemia and worsening of pre‑existing diabetes are also important metabolic risks that require monitoring.

Patients with active malignancy, severe uncontrolled diabetes, acute critical illness, or known hypersensitivity to somatropin or any excipients should not receive the product. Contraindications also include patients with intracranial hypertension or those for whom growth hormone therapy offers no clinical benefit.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Somatropin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT